Product Code: GDIS2150MR
GlobalData's 'COVID-19 Impact on Bupa' report provides a snapshot of the impact on the Bupa in light of the COVID-19 outbreak.
It provides the impact of revised GDP growth estimates on growth prospects of Bupa, exposure of the product portfolio and exposure by country/region due to virus outbreak.
The report brings together GlobalData's research, modeling and analysis expertise, giving access to information on the projected impacts of the outbreak on the insurer.
This report provides in-depth company analysis, information and insights of COVID-19 impact on Bupa.
- Exposure of the insurer to regions and countries impacted by COVID-19
- Key lines of businesses across regions where the insurer's books are potentially impacted
- Share of key lines of businesses by country/region in context of COVID-19 impact
This report provides a comprehensive analysis of the impact of COVID-19 on Bupa -
- It provides insights on Bupa exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the key business lines of the insurer that could be impacted due to the COVID-19 outbreak.
Reasons to Buy
- Take a strategic view of the business exposure of leading global insurers in COVID-19 outbreak.
- Understand the key factors shaping the growth and profitability outlook of the insurer.
Table of Contents
Table of Contents
1. Key findings as of July 10, 2020
- COVID-19 Impact Analysis on Bupa - Key findings
- Geographic spread analysis - COVID-19 vs Bupa's lines of business
2. Regional Impact
- The impact of COVID-19 on regional GDP levels
- Bupa's Exposure: Life, Non-Life and PA&H Insurance Premium by Region vs Regional Impact Levels
- Non-Life Exposure: Premium by Region and Segment vs Regional Impact Levels
- Life Insurance Exposure: Premium by Region and Segment vs Regional Impact Levels
- PA&H Exposure: Premium by Region and Segment vs Regional Impact Levels
3. Company Reaction
- Indications from recruitment trends
- Indications from stock pricing and sentiment scores
4. COVID-19 Impact Scores: Bupa and other companies
6. About GlobalData